Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00192777
Status:
UNKNOWN
Last Update Posted:
2007-10-08
First Post:
2005-09-13
Brief Title:
Concurrent Xeloda and Radiotherapy for Bone Metastases
Sponsor:
Rambam Health Care Campus
Organization:
Rambam Health Care Campus
Study Overview
Official Title:
Concurrent Xeloda and Radiotherapy for Bone Metastases
Status:
UNKNOWN
Status Verified Date:
2005-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hypothesis Radiosensitization using Xeloda should improve the rate of complete pain relief
Primary Objective
To determine the frequency of pain relief for the proposed regimen
Secondary Objectives
To determine the duration of pain relief and narcotic relief for the proposed regimen
To determine the frequency of narcotic relief for the proposed regimen
To determine the toxicity of concurrent UFT and radiotherapy in patients with bone metastases
Primary Objective
To determine the frequency of pain relief for the proposed regimen
Secondary Objectives
To determine the duration of pain relief and narcotic relief for the proposed regimen
To determine the frequency of narcotic relief for the proposed regimen
To determine the toxicity of concurrent UFT and radiotherapy in patients with bone metastases
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None